Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effectiveness and safety of risperidone compared with haloperidol and placebo in chronic schizophrenia; the study has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)
• Risperidone (Risperdal) (Risperidone)

Snippet

Sponsor: Janssen, LP | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED